Skip to main content
Premium Trial:

Request an Annual Quote

John Rossi, Mark Behlke, Carlo Croce, Frank McCormick, Thomas Roberts, Muneesh Tewari

Premium
Dicerna Pharmaceuticals said this week that it has established its scientific advisory board.
 
Joining the SAB are John Rossi, a researcher at the City of Hope and Dicerna co-founder; Mark Behlke, CSO of Integrated DNA Technologies and Dicerna co-founder; and Carlo Croce, a professor at Ohio State University.
 
Also joining the SAB is Frank McCormick, a professor at the University of California, San Francisco, and Thomas Roberts, a professor at Harvard Medical School.
 

 
CombiMatrix has named Muneesh Tewari to its scientific advisory board.
 

Tewari is a researcher at the Fred Hutchinson Cancer Research Center.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.